{"nctId":"NCT03220958","briefTitle":"Metoclopramide for Post Traumatic Headache","startDateStruct":{"date":"2017-08-01","type":"ACTUAL"},"conditions":["Post-Traumatic Headache"],"count":160,"armGroups":[{"label":"Metoclopramide","type":"EXPERIMENTAL","interventionNames":["Drug: Metoclopramide","Drug: Diphenhydramine","Drug: Normal saline"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Normal saline"]}],"interventions":[{"name":"Metoclopramide","otherNames":[]},{"name":"Diphenhydramine","otherNames":[]},{"name":"Normal saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nIncluded patients will be adults who meet International Classification of Headache Disorders criteria for acute post-traumatic headache. These are as follows:\n\n* Traumatic injury to the head has occurred\n* Headache has developed within 7 days of injury to the head\n* Headache is not better accounted for by another diagnosis (eg, previous history of migraine or tension-type headache)\n\nThe headache must be rated as moderate or severe in intensity at the time of initial evaluation.\n\nExclusion Criteria:\n\nPatients will be excluded if more than ten days have elapsed since the head trauma, if the headache has already been treated with an anti-dopaminergic medication, or for medication contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use of MAO inhibitors, and use of anti-rejection transplant medications.","healthyVolunteers":false,"sex":"ALL","genderBased":true,"minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"0-10 Pain Scale on Which 0 = no Pain and 10= the Worst Pain Imaginable","description":"Improvement in this 0 to 10 verbal rating scale","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":"2.3"},{"groupId":"OG001","value":"3.8","spread":"2.6"}]}]}]},{"type":"SECONDARY","title":"Sustained Headache Relief","description":"Achieving a headache intensity of mild or none in the ED without use of rescue medication and maintaining a level of mild or none. Participants rate their headache as none, mild, moderate, or severe","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Headache Days","description":"Number of days with any headache. Participants report the actual number of days they experienced headache. A \"day\" begins when they awake for the beginning of daily activities and ends when they go to sleep after completion of daily activities","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"1.6"},{"groupId":"OG001","value":"3.3","spread":"1.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":81},"commonTop":["Drowsiness","Post-concussive syndrome","Various other","Akathisia","Dizziness"]}}}